TY  - GEN
AU  - Yu,H
AU  - MacIsaac,D
AU  - Wong,J J
AU  - Sellers,Z M
AU  - Wren,A A
AU  - Bensen,R
AU  - Kin,C
AU  - Park,K T
TI  - Market share and costs of biologic therapies for inflammatory bowel disease in the USA
SN  - 1365-2036
PY  - 2019///0312
KW  - Administrative Claims, Healthcare
KW  - statistics & numerical data
KW  - Adolescent
KW  - Adrenal Cortex Hormones
KW  - economics
KW  - Adult
KW  - Biological Products
KW  - Biological Therapy
KW  - Child
KW  - Child, Preschool
KW  - Costs and Cost Analysis
KW  - Databases, Factual
KW  - Female
KW  - Health Care Sector
KW  - Humans
KW  - Immunologic Factors
KW  - Infant
KW  - Infant, Newborn
KW  - Inflammatory Bowel Diseases
KW  - drug therapy
KW  - Longitudinal Studies
KW  - Male
KW  - Mesalamine
KW  - Retrospective Studies
KW  - United States
KW  - epidemiology
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1111/apt.14430
ER  -